300 related articles for article (PubMed ID: 35682744)
1. Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications.
Napolitano F; Montuori N
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682744
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
Whyte CS; Swieringa F; Mastenbroek TG; Lionikiene AS; Lancé MD; van der Meijden PE; Heemskerk JW; Mutch NJ
Blood; 2015 Apr; 125(16):2568-78. PubMed ID: 25712989
[TBL] [Abstract][Full Text] [Related]
3. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
4. Platelet-Mediated Modulation of Fibrinolysis.
Whyte CS; Mitchell JL; Mutch NJ
Semin Thromb Hemost; 2017 Mar; 43(2):115-128. PubMed ID: 28215042
[TBL] [Abstract][Full Text] [Related]
5. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
6. Endogenous fibrinolysis facilitates clot retraction in vivo.
Samson AL; Alwis I; Maclean JAA; Priyananda P; Hawkett B; Schoenwaelder SM; Jackson SP
Blood; 2017 Dec; 130(23):2453-2462. PubMed ID: 29074499
[TBL] [Abstract][Full Text] [Related]
7. Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets.
Baeten KM; Richard MC; Kanse SM; Mutch NJ; Degen JL; Booth NA
J Thromb Haemost; 2010 Jun; 8(6):1313-22. PubMed ID: 20180903
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
Kunitada S; FitzGerald GA; Fitzgerald DJ
Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
[TBL] [Abstract][Full Text] [Related]
9. Haemostasis.
Arnout J; Hoylaerts MF; Lijnen HR
Handb Exp Pharmacol; 2006; (176 Pt 2):1-41. PubMed ID: 17001771
[TBL] [Abstract][Full Text] [Related]
10. Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.
Boulaftali Y; Ho-Tin-Noe B; Pena A; Loyau S; Venisse L; François D; Richard B; Arocas V; Collet JP; Jandrot-Perrus M; Bouton MC
Circulation; 2011 Mar; 123(12):1326-34. PubMed ID: 21403095
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
Braaten JV; Jerome WG; Hantgan RR
Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
[TBL] [Abstract][Full Text] [Related]
12. The hemostatic system.
Stassen JM; Arnout J; Deckmyn H
Curr Med Chem; 2004 Sep; 11(17):2245-60. PubMed ID: 15379710
[TBL] [Abstract][Full Text] [Related]
13. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.
Sakharov DV; Nagelkerke JF; Rijken DC
J Biol Chem; 1996 Jan; 271(4):2133-8. PubMed ID: 8567670
[TBL] [Abstract][Full Text] [Related]
14. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
de Haan J; van Oeveren W
Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
[TBL] [Abstract][Full Text] [Related]
15. Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.
Mitchell JL; Lionikiene AS; Georgiev G; Klemmer A; Brain C; Kim PY; Mutch NJ
Blood; 2016 Dec; 128(24):2834-2845. PubMed ID: 27694320
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets.
Lishko VK; Yermolenko IS; Ugarova TP
J Thromb Haemost; 2010 Apr; 8(4):799-807. PubMed ID: 20095998
[TBL] [Abstract][Full Text] [Related]
18. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
Savchuk AN
Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
[TBL] [Abstract][Full Text] [Related]
19. Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.
Suzuki Y; Sano H; Mochizuki L; Honkura N; Urano T
Blood Adv; 2020 Nov; 4(21):5501-5511. PubMed ID: 33166409
[TBL] [Abstract][Full Text] [Related]
20. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
